000			02016 a2200577 4500
005			20250514161928.0
264		0	_c20040816
008			200408s 0 0 eng d
022			_a0142-9612
024	7		_a10.1016/s0142-9612(03)00556-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aCrotti, T N
245	0	0	_aFactors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. _h[electronic resource]
260			_bBiomaterials _cFeb 2004
300			_a565-73 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCarrier Proteins _xmetabolism
650	0	4	_aFemale
650	0	4	_aForeign-Body Reaction _xetiology
650	0	4	_aGlycoproteins _xmetabolism
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins _xmetabolism
650	0	4	_aMiddle Aged
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aOsteoarthritis _xmetabolism
650	0	4	_aOsteoclasts _xmetabolism
650	0	4	_aOsteolysis _xetiology
650	0	4	_aOsteonecrosis _xetiology
650	0	4	_aOsteoprotegerin
650	0	4	_aProsthesis Failure
650	0	4	_aProsthesis-Related Infections _xetiology
650	0	4	_aRANK Ligand
650	0	4	_aReceptor Activator of Nuclear Factor-kappa B
650	0	4	_aReceptors, Cytoplasmic and Nuclear _xmetabolism
650	0	4	_aReceptors, Tumor Necrosis Factor
700	1		_aSmith, M D
700	1		_aFindlay, D M
700	1		_aZreiqat, H
700	1		_aAhern, M J
700	1		_aWeedon, H
700	1		_aHatzinikolous, G
700	1		_aCapone, M
700	1		_aHolding, C
700	1		_aHaynes, D R
773	0		_tBiomaterials _gvol. 25 _gno. 4 _gp. 565-73
856	4	0	_uhttps://doi.org/10.1016/s0142-9612(03)00556-8 _zAvailable from publisher's website
999			_c14345064 _d14345064